Child-Adult Atopic Dermatitis Research Trial 1 (8 Weeks)

Children and adults aged 6 years or older with a diagnosis of atopic dermatitis (AD), may qualify to participate. Individuals must have mild to moderate AD with involvement of 3% or more body surface area (BSA) A history of AD for at least 3 months (if 6-17 years of age) or 6 months (if 18+ years of age) is required along with stable disease for the past 4 weeks with no significant flares, before screening.

Participants will receive investigational topical medication (active study drug) or placebo, via a cream. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 8 weeks and involve about 5 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more